100 лет не замечали главную причину рака. Теперь мы знаем.

Scientific concepts, discoveries, and nature/biological phenomena

Core argument: cancer as a self-sustaining “loop”

• Cancer is framed as a process rather than a single broken component.
• Tumors can be heterogeneous—different genetic/metabolic states can exist in different regions—so a therapy aimed at one “button” may fail if the rest of the tumor (“trunk”) persists.
• The central proposed mechanism is a feedback cycle (“loop”) involving:
  • Gene programs that enhance growth and survival
  • Metabolic reprogramming, especially glucose → lactate via glycolysis
  • Tumor microenvironment changes, such as acidification
  • Immune suppression/evasion
  • Possibly epigenetic/chromatin changes that alter gene expression
• The loop results in more lactate and more tumor-supportive conditions, reinforcing itself.

Targeted therapy and the “multiple buttons” problem

• Targeted therapy typically works by:
  • Performing a biopsy
  • Identifying mutations/altered pathways
  • Using a drug to block a critical tumor signaling weakness
• Limitation:
  • Tumors evolve and vary spatially, so one biopsy may miss key subclones.
  • A drug may suppress one branch but not the whole system, leading to relapse.

Tumor heterogeneity example (kidney cancer)

• Researchers sampled multiple regions within the same tumor.
• Finding described: across many samples, the tumor showed different genetic patterns, supporting a “tumor tree” model:
  • Trunk = early changes present in most cells
  • Branches = later divergent changes driven by continued growth, selection, immune/treatment evasion

Warburg effect (historical metabolism observation)

• Otto Warburg observed that tumor cells often:
  • Prefer glycolysis (glucose breakdown) even when oxygen is available (aerobic conditions)
  • Produce large amounts of lactate
• This pattern is called the Warburg effect, contrasted with normal cells that oxidize glucose more fully when oxygen is present.

Lactate re-framed: from waste to fuel to signal

• Lactate is described as:
  • Fuel in normal physiology (used by muscle, heart, brain)
  • A regulated part of metabolic cycles during exercise
• In tumors, lactate production is chronic (day and night) and becomes:
  • A signal and part of the pathological microenvironment
  • A contributor to acidic conditions that hinder immune cell function
  • A participant in communication between metabolism and gene regulation

Tumor microenvironment (TME)

• The tumor is presented as living within a surrounding system including:
  • Blood vessels
  • Immune cells
  • Connective tissue
  • Oxygen and nutrient levels
  • Acidity (pH)
  • Signaling molecules
• The tumor can “train” this neighborhood to favor tumor survival by:
  • Increasing acidity
  • Disrupting immune surveillance/effector function
  • Influencing nearby cells to support growth

“Lactateation” / lactate-associated chromatin/epigenetic marking (2019 claim)

• The subtitles refer to “histone lactation” (likely meaning lactate-linked histone modifications).
• Proposed mechanism:
  • DNA is packaged around histones (“protein coils”)
  • Chemical marks on histones can change which genes are more accessible/active
• Claim described (in studies noted on macrophages/immune cells):
  • Lactate accumulation coincided with new histone labels and activation of regenerative-related genes (example given: Arc1)
• Core principle emphasized:
  • A metabolic molecule (lactate) can act as a signal influencing gene reading

Oncometabolite concept

• Lactate is proposed as a possible oncometabolite:
  • A metabolite that can contribute to tumor behavior, not merely be a byproduct
• Caution included:
  • Lactate is not claimed to be the sole cause of cancer.
  • Exercising does not “cause cancer”; normal lactate signals differ from tumor-associated chronic lactate signaling.

Clinical implication: why single-target strategies often fail

• If cancer relies on interacting systems (genes + metabolism + immune evasion + microenvironment), then:
  • Inhibiting one protein or enzyme may be bypassed or compensated
  • Different tumor regions may use different “solutions” to therapy

Treatment/prevention framing

• The subtitles argue against “one-button thinking,” such as:
  • “Remove all sugar”
  • “Block lactate”
  • “Fasting as a universal solution”
• Instead, prevention is framed as reducing long-term conditions that make pathological loops easier to sustain, including:
  • Obesity
  • Insulin resistance
  • Low muscle mass
  • Sedentary lifestyle
  • Poor sleep
  • Chronic inflammation
• Exercise is framed as supporting proper metabolic cycle closure:
  • Better mitochondrial function
  • Better management of glucose, fats, and lactate dynamics (not eliminating lactate)

Research directions mentioned (lactate transport and TME)

• If lactate plays a role, researchers are exploring:
  • Lactate transporters: MCT1 and MCT4
  • Tumor acidity mechanisms and consequences
  • Combining metabolic approaches with immunotherapy
  • How lactate influences tumor and immune cell behavior

---

Lists / methodologies mentioned

Logic of targeted therapy workflow (as described)

1. Take a tumor biopsy
2. Determine:
   • Mutations
   • Damaged genes/pathways
   • Which signals the tumor uses for growth
3. Identify a drug target (“button”)
4. Use a drug to block the signal
5. Expect tumor growth to stop (sometimes works, but can fail with heterogeneity)

How tumor heterogeneity is studied (as described for kidney cancer)

• Collect many samples from different tumor regions
• Compare genetic patterns across locations
• Infer early shared changes vs later divergent subclones

---

Researchers/sources featured (names mentioned in subtitles)

• Otto Warburg
• Iniga San Milan (as written in subtitles)
• Brooks (as written in subtitles; co-named with San Milan for proposing lactate as a possible oncometabolite)
• He ston / Heston (as written; referenced in the context of histones and the 2019 “histone lactation” discovery—name appears garbled in subtitles)
• Arc1 (gene name mentioned; included as an example in the subtitles)